chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a health professional referring to unspecified numbers of patients of unknown age and gender. There was no information about the patients' medical history and concurrent condition. On unknown dates, these patients were vaccinated with doses of improperly stored VAQTA (lot # reported as 1028666, expiration date: 04-NOV-2016, strength, dose and route unknown). There was no information about concomitant therapy. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient was administered Moderna vaccine on 04/23/21 in order to avoid waste of vaccine. At the time, the facility checked MAR to verify patient had not received vaccine. At the time patient was unknown to have recevied a Pfizer Covid Vaccine. Staff looked at electronic MAR on 4/27 and found that the patient had received a Pfizer vaccine in January and never followed up with a secondary shot. State immunization department was contacted and told no to administer any further doses at this time. Patient will be followed up and ensure that they remain in stable conditions. No other shots will be administered at this time.
kind of looks like measles; a rash between fingers and on the backs of hands; rash.. that itches; This spontaneous case was reported by an other and describes the occurrence of RASH MORBILLIFORM (kind of looks like measles), RASH (a rash between fingers and on the backs of hands) and RASH PRURITIC (rash.. that itches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH MORBILLIFORM (kind of looks like measles), RASH (a rash between fingers and on the backs of hands) and RASH PRURITIC (rash.. that itches). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and TOPICAL STEROIDS at an unspecified dose and frequency. At the time of the report, RASH MORBILLIFORM (kind of looks like measles), RASH (a rash between fingers and on the backs of hands) and RASH PRURITIC (rash. that itches) was resolving.            No relevant concomitant medications were reported.
Hives started 1 week after vaccine. Started on medrol dose pack, now improving - not yet resolved.
Patient came in to get a 2nd dose of her Moderna vaccine but instead of getting a full dose (0.5 mL), she got the booster dose (0.25 mL). She is approximately 4 months pregnant. She didn't have any adverse reactions to the vaccine and she left the vaccine clinic after waiting her 15 minutes.
Next morning woke up with progressive nausea, headache, muscle aches, chills, and arm soreness
Extremely painful at site of shot. Today only moderate pain. Feeling generally unwell, uncharacteristically pale, and tired today.
got the shot was never so sick patient in life; Initial information received on 18-Nov-2020 regarding an unsolicited valid non-serious case from social media. Via consumer or non-health care professional (Patient).  This case involves adult patient (gender not specified) who got the INFLUENZA VACCINE [shot] was never so sick patient in life (illness).  It was unknown if the patient had any medical history, concomitant disease or risk factor. Medical treatment, vaccination and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number not and expiry date not reported] via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient got the shot was never so sick patient in life (illness) (non-serious) unknown latency following the administration of INFLUENZA VACCINE.  There were no lab data/results available.  It was not reported if the patient received any corrective treatment.  At the time of reporting, the event outcome reported as unknown for event.  There will be no information available on the batch number for this case.
Patient's mother reported that he broke out in mild chickenpox rash 3-4 days after vaccination.  She applied Caladryl lotion to alleviate discomfort.  Symptoms resolved.
pt recv vax 24APR97 & mom reports 29APR97 that lt arm red/swollen, c/o that arm hurt;mom also states pt broke out in chickenpox on 27APR97;worried something might be wrong;mom in clinic 1MAY97;
This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Dry cough), OROPHARYNGEAL PAIN (Sore throat), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell) and INFLUENZA LIKE ILLNESS (flu like symptoms) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes mellitus. Concomitant products included HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN/HCTZ) and INSULIN GLARGINE (LANTUS) for an unknown indication.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced COUGH (Dry cough), OROPHARYNGEAL PAIN (Sore throat), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), INFLUENZA LIKE ILLNESS (flu like symptoms), DIARRHEA (Diarrhea), PAIN (Body aches), CHILLS (Chills), PYREXIA (Fever) and VOMITING (Vomiting). The patient was treated with CEFDINIR for Dry cough and Sore throat, at a dose of 300 mg twice a day and BENZONATATE for Dry cough and Sore throat, at a dose of 200 mg three times a day. At the time of the report, COUGH (Dry cough), OROPHARYNGEAL PAIN (Sore throat), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), INFLUENZA LIKE ILLNESS (flu like symptoms), DIARRHEA (Diarrhea), PAIN (Body aches), CHILLS (Chills), PYREXIA (Fever) and VOMITING (Vomiting) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient stated that she was doing better
started vomiting 15hr p/vax;has vomited x 3 & is running temp of 102 po;has not given any APAP;
Nine hours after immunizations pt developed a low grade temperature and experienced a seizure. Pt was transported to ER and now will be worked up and followed. 1st time seizure
Dizziness and pale, no shortness of breath, no swollen tongue, no fever, no redness to site of injection.
sore arm; little tired; bad headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), FATIGUE (little tired) and HEADACHE (bad headache) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022HPVP and 030BZIA) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) and CITALOPRAM HYDROBROMIDE (CELEXA [CITALOPRAM HYDROBROMIDE]) for Allergy.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm), FATIGUE (little tired) and HEADACHE (bad headache). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 29-Mar-2021, PAIN IN EXTREMITY (sore arm) had resolved. On 30-Mar-2021, HEADACHE (bad headache) had resolved. At the time of the report, FATIGUE (little tired) outcome was unknown.            Action taken with mRNA-1273 in response to the events were not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-101504 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-101504:Second dose case
Rash with welts on chest and abdomen/trunk of body started within 12 hrs of receiving vaccine.
DISCOLOURATION OF LIPS; DRYNESS OF LIPS; HEADACHE; FEVER; DIZZINESS; CHILLS; TIRED; This spontaneous report received from a patient concerned a 24 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known allergies no significant medical history. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609, and batch number: 1808609 expiry: UNKNOWN) dose was not reported, administered on 30-MAR-2021 11:00 for prophylactic vaccination. No concomitant medications were reported. On 30-MAR-2021, the subject experienced chills. On 30-MAR-2021, the subject experienced tired. On 30-MAR-2021 11:00, the subject experienced dizziness. On 30-MAR-2021 18:00, the subject experienced fever. On 31-MAR-2021, the subject experienced headache. On 04-APR-2021, the subject experienced dryness of lips. On 10-APR-2021, the subject experienced discolouration of lips. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from dizziness on 30-MAR-2021 11:30, chills, headache, and fever on 31-MAR-2021, and tired on 04-APR-2021, and had not recovered from discolouration of lips, and dryness of lips. This report was non-serious.
Systemic: Dizziness / Lightheadness-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Numbness (specify: facial area, extremities)-Mild, Additional Details: patient has history of asthma, and had have same reaction with other vaccines before
Patient reported having sore left arm after getting the vaccine. On march 3/4th patient reported sever pain in the left shoulder area. Pain did not go away after OTC medications. restricted hand movement as well
Site: Bruising at Injection Site-Medium, Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Itch Generalized-Medium
10 days after vaccine localized reaction, possible cellulitis at site of injection occurred. (site of injection of varicella). At day 3 of abx significant improvement.
Day8 after vaccine, lymph nodes in armpit of same arm that had vaccine became enlarged, tender. Injection site became red, burning, itching, and covered majority of deltoid.
This spontaneous report as received from a nurse refers to unspecified patients of unknown demographics. No information about medical history, drug reactions and allergies were specified. On an unknown date in September 2014 over the past 3 to 4 weeks, the patients were vaccinated with ROTATEQ (lot #, dose, route not reported) for. No concomitant medications were reported. No symptoms reported. There was no product quality complaint. The outcome is unknown. This is one of the three reports received from the same reporter (MARRS # 1410USA004187 and MARRS # 1410USA005092). Additional information has been requested.
A patient received 2 vaccinations within same pregnancy one month apart, no AE; Vaccine exposure during pregnancy; Initial information was received on 01-Mar-2021 regarding an unsolicited valid non-serious case from a pharmacist in the United States.  This case involves a female patient (age not reported) who received a dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] (Suspension for injection, batch number and expiry date not reported) via an unknown route in an unknown administration site for prophylactic vaccination within same pregnancy one month apart (at 31 weeks and 35 weeks) on an unknown date (Extra dose administered) on an unknown date while she was pregnant.  The date of last menstrual period was not reported.  The estimated due date was not reported.  Past medical treatment, vaccination and family history were not provided.  It was unknown if the patient had any medical history, concomitant disease or risk factor.  It was case of vaccine exposure during pregnancy.   Pregnancy outcome was unknown at the time of report.  It was unknown if the patient experienced any additional symptoms/events.   The details of medication and reason for taking the medicine were not reported.  It was unknown if there were lab data/results available.  This was a case of actual medication error due to extra dose administered (latency unknown).  At the time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  There will be no information available on batch number for this case.
One day post immunizations rash started on chest and has spread to back. Macular rash on chest. Give teaspoon of BENADRYL for itching.
Noted redness, swelling, tenderness of L arm one day post receiving DTaP #5 in that arm, + tactile fever, + extension of swelling over next day. No SOB, hives. Will receive Keflex 250mg po TIDx10days.
23OCT89 pt vax 2nd hepta B; devel local edema & swelling w/pain from shoulder to fingertips & marked swelling at inject site.  Right arm painful for 10 days.
13 Days post vaccinations of Pro Quad child developed fever 99.0 and red rash on chest, back and top of thighs.
Currently 19 weeks pregnant, with second child. Due date 7/23/21. Age 37.
This spontaneous report was received from a respiratory therapist refers to a one among 23 unspecified patients, age and gender were unknown. Medical history was not reported. The respiratory therapist informed that between 01-FEB-2014 through 31-MAY-2014 the patient was vaccinated with PNEUMOVAX 23, lot number T015866 expiration date 25-FEB-2015 (route, strength and dosage were not reported), which was improperly stored. Concomitant therapy was not reported. No adverse effects were reported. No product quality complaint (PQC) filed. The action taken was assessed as not applicable. The causality was assessed as not related to the suspect therapy. This is one of several reports received from the same reproter. Follow up information has been received. Lot number T015866 is an invalid lot numbers for PNEUMOVAX 23. Additional information has been requested.
Information has been received from the doctor's employee concerning an over 60 year old male who "recently" was vaccinated with ZOSTAVAX (Merck). A week later the patient came in and had shingles. The patient sought unspecified medical attention and the outcome of the patient was unknown. Additional information has been requested.
dizziness; sweating; feel like puking; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 66 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious), outcome "unknown", described as "dizziness"; HYPERHIDROSIS (non-serious), outcome "unknown", described as "sweating"; NAUSEA (non-serious), outcome "unknown", described as "feel like puking".  Additional information: Reporter stated that, patient received Pfizer-BioNTech COVID-19 vaccine this morning and after a couple of hours, patient experienced symptoms.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
experienced "arthritic pain in her shoulders and hands" and was not able to be "functional".; hand was swollen; was not able to be functional; This is a spontaneous report from a contactable consumer or other non hcp. A 6-decade-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date (9 days after getting cortisone shots in each of her arms) as dose 2, single for COVID-19 immunization. The patient's medical history was not reported. Concomitant medication(s) included cortisone shots taken for an unspecified indication, start and stop date were not reported. The patient experienced arthritic pain in her shoulders and hands and was not able to be functional and hand was swollen for 3 days then as it subsided, her other hand got swollen for 3 days also on an unspecified date. It was reported that, she was unable to open a water bottle/cap in the morning but was capable at night. She had 2 steroid treatment and finished her second one. She was a tennis player and still could not do any of that. Therapeutic measures were taken as a result of events. The outcome of the events was unknown.  Information on the lot/batch number has been requested.  No follow-up attempts are completed; information about lot/batch number cannot be obtained.
Soreness at injection site.  Progressing to pain up to neck and down to elbow.  Pain present for 1 week at this point.
At Day 8, the injection site suddenly developed an itchy bump 1/2 inch across and a rash surrounding the bump 3 inches across.  It is quite itchy.  It was a sudden onset on Day 8, without any precursor except a slight itchiness on Day 2 that resolved by Day 3.
2-3 hours after vaccination I felt intense tingling in both arms, hands, feet, and legs. The tingling did not feel like numbness or static. After 10-15 minutes the tingling subsided into shivering, but I did not feel cold. The shivering went away about 15 minutes later. 30 minutes after that, the same pattern and duration of tingling and shivering happened again. The next day (about 24 hours after vaccination) I felt very nauseous and had a bad headache that lasted about 4 hours.
This spontaneous report as received from a physician via a company representative refers to a female patient of unknown age. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX intramuscularly instead of subcutaneously for prevention of shingles (lot # and expiration date were not reported). On an unknown date, the patient experienced swelling and redness. The patient saw the reporting physician due to the events. The outcome of the events and the relatedness between the events and ZOSTAVAX were not reported. Additional information is not expected as there is no consent to contact the reporter.
The night after receiving vaccines (8 pm) he started twitching (10 sec) (extremities) after the 10 sec he had a few more jerks of arm/leg then he was fine. Slept through night. This A.M. had a few shoulder jerks, but not like night before. He's been happy. No vom, diarrhea.
This spontaneous report as received from a female patient of unknown age refers to herself. On 02-JAN-2015 the patient was vaccinated with ZOSTAVAX 1 single shot (dose, route and lot# unknown). The patient reported, in approximately January 2015, "after received ZOSTAVAX, she developed a bad cold and she have coughed up a thick substance'. The patient had sought medical attention by spoke with pharmacist. The outcome of the events was reported as not recovered/not resolved. No PQC (Product Quality Control) involved. Additional information is not expected since no reporter contact information.
1/16/07 Reported weakness from vaccination date on 1/11/07 noted episodes of shaking-even in bed.  1/13/07 continued shaking, bones and muscles ached, awoke sweating in drenched bed Sat and Sun nights. No temp taken, no temp symptoms, post menopausal, dehydration.
Hepatitis B #2 vaccine given 9-3-10 (Fri). She woke up Sat AM with a small knot size of dime & she felt lightheaded & only wanted to sleep. Sunday AM 9-5-10 woke up vomiting headache, weakness & swollen, large (L) upper arm at vaccine site. She went to ED 4cm reaction. NORCO given, & antiemetic.
Almost immediately following the immunizations pt experienced extreme, debilitating headache with nausea.   Progressively became a 10 out of 10 on pain scale.  Mom called EMS and patient was transported to ED.  Pt was given a CT scan which was negative.  In ED pt received Ketorolac 30mg IV as well as Ondansetron 4mg IV.   Symptoms resolved after a few hours.
Toddler became unable to put any pressure on leg that injection was administered in.  Took. Hold to ER where an X-ray was done and any injury was ruled out. There was still. So sable knot in the leg where injection site was. Doctor determined treatment to be Motrin and heating pad on lump at injection site. This seems to be working.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. No information regarding the patients' medical history was provided. On an unknown date the patients were vaccinated with VARIVAX (Merck) that had been exposed to 7 F for an unknown period of time. It was reported that it seemed that the product was stored at 7 F for months. No concomitant medication was reported. No adverse symptoms were reported. No outcome was reported. Additional information has been requested.
5 minute seizure.  Mom thinks he was developing a fever at the time, but did not have a documented temp.  No shaking, but zoned out for five minutes and became pale.  Called EMS, but they observed him and left without transporting.  He recovered completely.
Developed severe "worse than ever" tinnitus in ears bilaterally in morning after vaccination No other focal neurologic changes Supportive measures reviewed
I95.9 HYPOTENSION 4/13/2023 UTI (URINARY TRACT INFECTION) I95.9 HYPOTENSION 4/13/2023 ANEMIA OF CHRONIC DISEASE
The first night i broke out into fever and sweats, a week later i was unable to move my neck (lasted 3 days),  During that same week i broke out into hives.  I have not gotten a period since the vaccination.  My last cycle would have began 9/30/2021, it is 2/19/2022. I am no longer taking birth control and i am not pregnant.
1) Rapid heartbeat, multiple incidences in the days after vaccination. No treatment, still in process of experiencing these incidents. 2) Tinnitus
Temp at home to 104.7, runny nose, decreased oral intake for 2 days prior; temp 105.7 at ED on 10/09, dx'd with bilateral otitis media, tx'd with antibiotics. Clinic visit on 10/11 with persistent symptoms, temps to 102, dx'd with viral syndrome.  Further follow up after this not available at the present time.
This case was reported by a healthcare professional and described the occurrence of injection site tenderness in a female subject of unspecified age who was vaccinated with FLULAVAL (GlaxoSmithKline).  On 4 October 2010 the subject received a dose of FLULAVAL (details unknown). On either 4 or 5 October 2010, less than one week after vaccination with FLULAVAL, the subject experienced a 2-4 inch area of injection site tenderness, injection site redness and hotness at injection site. At the time of reporting the events were improved. The healthcare professional reported that she gave approximately 40 vaccinations to employees and has had 7 reports of a 2-4 inch area around the injection site that was tender, red and warmer than the surrounding skin. This is case 2 of 7 (see case IDs A0885121A, A0885269A - A0885273A for the other reports). The healthcare professional also reported an additional subject who experienced different adverse events following vaccination with FLULAVAL (see case ID A0885114A for more details). Follow-up information received on 26 October 2010 indicated that the subject was 45 years old at the time of events. No additional information was reported.
had a fever of 103 ax 3 hrs p/receiving shots, fever cont for approx 5 hrs;